Novartis AG
NVS· NYSE
NVSNovartis AG
Source filing unavailable
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | $4.04B | $3.25B | $2.32B | $1.69B |
| EPS Diluted | $2.06 | $1.59 | $1.11 | $0.77 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Novartis AG · CIK 1114448 · Engraved from SEC EDGAR
